Want to join the conversation?
$GS's compensation and benefits to net revenues ratio was 40% in YTD 2015, which is 200 BPs lower than 1H15 and consistent with YTD 2014. Non-compensation expenses were 30% lower than 2Q15. Net provisions for litigation and regulatory expenses in 3Q15 were $416MM.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?